18.62
price up icon4.78%   0.85
after-market After Hours: 18.62
loading
Entrada Therapeutics Inc stock is traded at $18.62, with a volume of 151.96K. It is up +4.78% in the last 24 hours and up +9.08% over the past month. Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
See More
Previous Close:
$17.77
Open:
$18.05
24h Volume:
151.96K
Relative Volume:
1.18
Market Cap:
$692.66M
Revenue:
$239.40M
Net Income/Loss:
$104.44M
P/E Ratio:
-7.2171
EPS:
-2.58
Net Cash Flow:
$-18.50M
1W Performance:
+7.75%
1M Performance:
+9.08%
6M Performance:
+41.49%
1Y Performance:
+11.83%
1-Day Range:
Value
$17.25
$18.62
1-Week Range:
Value
$17.04
$18.62
52-Week Range:
Value
$10.75
$18.62

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Name
Name
Entrada Therapeutics Inc
Name
Phone
857-305-1825
Name
Address
ONE DESIGN CENTER PLACE, BOSTON
Name
Employee
168
Name
Twitter
Name
Next Earnings Date
2024-08-12
Name
Latest SEC Filings
Name
TRDA's Discussions on Twitter

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-24 Initiated Oppenheimer Outperform
Apr-03-23 Initiated H.C. Wainwright Buy

Entrada Therapeutics Inc Stock (TRDA) Latest News

pulisher
11:13 AM

Entrada Therapeutics : Corporate Presentation - Marketscreener.com

11:13 AM
pulisher
07:29 AM

Entrada Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times

07:29 AM
pulisher
Nov 02, 2024

Here's Why Momentum in Entrada Therapeutics (TRDA) Should Keep going - MSN

Nov 02, 2024
pulisher
Oct 28, 2024

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Short Interest Down 19.1% in October - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Short Interest in Entrada Therapeutics, Inc. (NASDAQ:TRDA) Declines By 19.1% - Defense World

Oct 28, 2024
pulisher
Oct 19, 2024

Here's What Could Help Entrada Therapeutics (TRDA) Maintain Its Recent Price Strength - MSN

Oct 19, 2024
pulisher
Oct 19, 2024

Entrada Therapeutics president sells $10,800 in stock By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 18, 2024

Natarajan Sethuraman Sells 600 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Insider Sale at Entrada Therapeutics Inc (TRDA) by President of Research & Development - GuruFocus.com

Oct 18, 2024
pulisher
Oct 17, 2024

There Is A Reason Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Price Is Undemanding - Simply Wall St

Oct 17, 2024
pulisher
Oct 15, 2024

Oppenheimer Initiates Coverage of Entrada Therapeutics (TRDA) with Outperform Recommendation - MSN

Oct 15, 2024
pulisher
Oct 14, 2024

(TRDA) Trading Report - Stock Traders Daily

Oct 14, 2024
pulisher
Oct 14, 2024

The Manufacturers Life Insurance Company Purchases 2,146 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Oct 14, 2024
pulisher
Oct 10, 2024

Renaissance Technologies LLC Invests $636,000 in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

Entrada Therapeutics advances Duchenne treatment trials - Investing.com

Oct 09, 2024
pulisher
Oct 09, 2024

Entrada Therapeutics advances Duchenne treatment trials By Investing.com - Investing.com UK

Oct 09, 2024
pulisher
Oct 09, 2024

Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society - The Manila Times

Oct 09, 2024
pulisher
Oct 03, 2024

(TRDA) Trading Advice - Stock Traders Daily

Oct 03, 2024
pulisher
Oct 01, 2024

Morguard Un (MRT-UN-T) QuotePress Release - The Globe and Mail

Oct 01, 2024
pulisher
Oct 01, 2024

Pompe Disease Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Market Dynamics, MOA, ROA by DelveInsight | M6P Therapeutics, Entrada Therapeutics, Maze Therapeutics, Astellas - The Globe and Mail

Oct 01, 2024
pulisher
Oct 01, 2024

Entrada Therapeutics COO sells shares worth over $13,000 - Investing.com India

Oct 01, 2024
pulisher
Oct 01, 2024

Entrada Therapeutics COO sells shares worth over $13,000 By Investing.com - Investing.com Australia

Oct 01, 2024
pulisher
Sep 30, 2024

Insider Sale: President & COO Nathan Dowden Sells Shares of Entr - GuruFocus.com

Sep 30, 2024
pulisher
Sep 27, 2024

Entrada Therapeutics (NASDAQ:TRDA) Trading 4.8% Higher - MarketBeat

Sep 27, 2024
pulisher
Sep 25, 2024

U.S. Gold Corp (USAU-Q) QuotePress Release - The Globe and Mail

Sep 25, 2024
pulisher
Sep 24, 2024

Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development - Markets Insider

Sep 24, 2024
pulisher
Sep 24, 2024

Entrada Therapeutics appoints new President of R&D - Investing.com

Sep 24, 2024
pulisher
Sep 23, 2024

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Sep 23, 2024
pulisher
Sep 23, 2024

30 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Itau Unibanco Holding S.A. - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

STERIS plc (NYSE:STE) Shares Sold by XTX Topco Ltd - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Mettler-Toledo International's (NYSE:MTD) investors will be pleased with their decent 100% return over the last five years - Simply Wall St

Sep 23, 2024
pulisher
Sep 23, 2024

Mutual of America Capital Management LLC Cuts Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 23, 2024
pulisher
Sep 22, 2024

Lavaca Capital LLC Acquires New Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Epoch Investment Partners Inc. - Defense World

Sep 22, 2024
pulisher
Sep 22, 2024

Seven Eight Capital LP Has $607,000 Stake in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Holdings Lowered by Ensign Peak Advisors Inc - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Entrada Therapeutics (NASDAQ:TRDA) Shares Up 6.7% - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

GM Advisory Group LLC Takes $214,000 Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Beddow Capital Management Inc. - Defense World

Sep 21, 2024
pulisher
Sep 21, 2024

Dimensional Fund Advisors LP Cuts Stake in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Shares Bought by Axxcess Wealth Management LLC - Defense World

Sep 20, 2024
pulisher
Sep 19, 2024

Entrada Therapeutics (NASDAQ:TRDA) Stock Price Up 6.7% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Tredje AP fonden Trims Stock Position in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Stake Reduced by Meiji Yasuda Asset Management Co Ltd. - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

XTX Topco Ltd Invests $2.49 Million in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Inspire Investing LLC Sells 357 Shares of Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Meiji Yasuda Life Insurance Co - Defense World

Sep 19, 2024
pulisher
Sep 17, 2024

Mettler-Toledo International Inc. (NYSE:MTD) Shares Purchased by Dai ichi Life Insurance Company Ltd - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Federated Hermes Inc. Has $10.72 Million Holdings in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors - Business Wire

Sep 17, 2024
pulisher
Sep 17, 2024

Quest Partners LLC Has $147,000 Stake in Mettler-Toledo International Inc. (NYSE:MTD) - Defense World

Sep 17, 2024

Entrada Therapeutics Inc Stock (TRDA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):